Product Description

Sermorelin

Product Overview

Sermorelin is a synthetic peptide consisting of 29 amino acids that corresponds to the biologically active portion of growth hormone-releasing hormone (GHRH). It has been studied for its ability to interact with GHRH receptors in the anterior pituitary gland, where it stimulates the release of growth hormone (GH).

As an analogue of naturally occurring GHRH, Sermorelin is of scientific interest in endocrine research examining pituitary function, growth hormone secretion, and the regulatory feedback mechanisms involved in the growth hormone and insulin-like growth factor 1 (IGF-1) pathways. Its shorter peptide structure provides a model for investigating the biological activity of GHRH-derived compounds and their interactions with endocrine signaling systems.

Research involving Sermorelin has included investigations of growth hormone stimulation and diagnostic assessment of pituitary function. Findings depend on the study population, formulation, and research setting, and should not be interpreted as establishing broader clinical benefits or long-term safety for unapproved uses.

Key Research Areas

Growth hormone-releasing hormone receptor activation

Pituitary function and growth hormone secretion

Growth hormone and IGF-1 signaling pathways

Endocrine feedback mechanisms and hormonal regulation

Structure–activity relationships of GHRH-derived peptides

Peptide characterization, stability, and analytical verification

Handling & Reconstitution

For laboratory use, reconstitute with Bacteriostatic Water (BAC) or sterile saline. After reconstitution, the solution should be stored at 2–8°C (36–46°F) and used within the appropriate experimental window to maintain peptide stability.